Discriminant analysis of the cognitive performance profile of MS patients differentiates their clinical course

Journal of Neurology

Volumn 252, Issue 7, 2005, Pages 808-813

  Kraus, Jürgen A ^a   Schütze, Cathleen ^a,b   Brokate, Barbara ^a   Kröger, Beate ^a   Schwendemann, Günther ^a   Hildebrandt, Helmut ^a,c  

^a KLINIKUM BREMEN OST   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

^c UNIVERSITY OF OLDENBURG   (Germany)

Author keywords

Cognitive impairment; Discriminant analysis; Multiple sclerosis

Indexed keywords

BETA INTERFERON;

ADULT; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; LANGUAGE TEST; MAJOR CLINICAL STUDY; MALE; MEMORY; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; PREDICTION; PRIORITY JOURNAL;

ADULT; ATTENTION; COGNITION DISORDERS; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; LANGUAGE; MALE; MEMORY; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PROBLEM SOLVING;

EID: 22144471486     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-005-0750-y     Document Type: Article

References (34)

1. Amato MP, Bartolozzi ML, Zipoli V, Portaccio E, Mortella M, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N (2004) Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 63:89-93
2. Arnett PA, Rao SM, Grafman J, Bernardin L, Luchetta T, Binder JR, Lobeck L (1997) Executive functions in multiple sclerosis: an analysis of temporal ordering, semantic encoding, and planning abilities. Neuropsychology 11:535-544
3. Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15:239-245
4. Bortz J (1993) Statistik, Berlin: Springer
5. Brassington JC, Marsh NV (1998) Neuropsychological aspects of multiple sclerosis. Neuropsychol Rev 8:43-77
6. Brokate B, Hildebrandt H, Eling P, Fichtner H, Runge K, Timm C (2003) Frontal lobe dysfunctions in Korsakoff's syndrome and chronic alcoholism: Continuity or discontinuity? Neuropsychology 17:420-428
7. Brück W, Lucchinetti C, Lassmann H (2002) The pathology of primary progressive multiple sclerosis. Mult Scler 8:93-97
8. Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C. et al. (1999) Cognitive function in primary progressive and transitional progressive multiple sclerosis. A controlled study with MRI correlates. Brain 122:1341-1348
9. Comi G, Filippi M, Martinelli V, Campi A, Rodegher M, Alberoni M, Sirabian G, Canal N (1995) Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 132:222-227
10. Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A, Willoughby E (1999) Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 122:871-882
11. D'Esposito M, Onishi H, Thompson J, Robinson L, Armstrong F, Grossman C (1996) Working memory impairments in multiple sclerosis: Evidence from a dual-task paradigm. Neuropsychology 1:51-56
12. DeSonneville LMJ, Boringa JB, Reuling IEW, Lazaron RHC, Ader HJ, Polman CH (2002) Information processing characteristics in subtypes of multiple sclerosis. Neuropsychologia 40: 1751-1765
13. Foong J, Rozewicz L, Chong WK, Thompons AJ, Miller DH (2000) A comparison of neuropsychological deficits in primary and secondary progressive multiple sclerosis. J Neurol 247:97-101
14. Foong J, Rozewicz L, Quaghebeur G, Davie CA, Kartsounis T, et al. (1997) Executive function in multiple sclerosis. The role of frontal lobe pathology. Brain 120:15-26
15. Gaudino EA, Chiaravalloti ND, DeLuca J, Diamond BJ (2001) A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis. Neuropsychiatry Neuropsychol Behav Neurol 14:32-44
16. Hildebrandt H, Brokate B, Lanz M, Ternes T, Timm C (2003) Exekutivfunktionsleistungen bei Patienten mit Multipler Sklerose. Aktuelle Neurologie 30:118-126
17. Hildebrandt H, Schwendemann G (2004) Kognitive Beeinträchtigungen bei Multipler Sklerose. Erscheint in A Zieger (Hrsg): Neurorehabilitation, Hippokampus Verlag
18. Kalkers NF, Bergers L, de Groot V, Lazeron RHC (2001a) Concurrent validity of the MS Functional Composite using MRI as a biological disease marker. Neurology 56:215-219
19. Kalkers NF, Bergers E, Castelijns JA, van Waldervee M (2001b) Optimizing the association between disability and biological markers in MS. Neurology 57:1253-1258
20. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907-911
21. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 123:1174-1183
22. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127
23. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389
24. Prosiegel M, Michael C (1993) Neuropsychology and multiple sclerosis: diagnostic and rehabilitative approaches. J Neurol Sci 115(Suppl): S51-S54
25. Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41: 685-691
26. Rovaris M, Filippi M (2000) MRI correlates of cognitive dysfunction in multiple sclerosis patients. J Neurovirol 6:172-175
27. Sailer M, Heinze HJ, Tendolkar I, Decker U, Kreye O (2001) Influence of cerebral lesion volume and lesion distribution on event-related brain potentials in multiple sclerosis. J Neurol 248:1049-1055
28. Thompson AJ, Montalban X, Barkhof F, Brochet B, Filippi M, Miller DH, Polman CH, Stevenson, VL, McDonald WI (2000) Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47:831-835
29. Thompson AJ, Polman CH, Miller DH, McDonald WI, Brochet B, Filippi M, Montalban X, De Sa J (1997) Primary progressive multiple sclerosis. Brain 120:1085-1096
30. Wishart H, Sharpe D (1997) Neuropsychological aspects of multiple sclerosis: A quantitative review. J Clin Exp Neuropsychol 19:810-824
31. Wolinsky JS (2003) The diagnosis of primary progressive multiple sclerosis. J Neurol Sci 206:145-152
32. Zakzanis KK (2000) Distinct neurocognitive profiles in multiple sclerosis subtypes. Arch Clin Neuropsychol 15: 115-136
33. Zerssen D von, Koeller D-M (1976) Die Beschwerdenliste. Weinheim: Beltz
34. Zivadinov R, Bakshi R (2004) Central Nervous System Atrophy and Clinical Status in Multiple Sclerosis. J Neuro Imag 14:27S-35S